The Current Ratio as of December 2025 (TTM) for LB Pharmaceuticals Inc Common Stock (LBRX) is 3.56

According to LB Pharmaceuticals Inc Common Stock’s latest financial reports and current stock price. The company's current Current Ratio is 3.56. This represents a change of -13.35% compared to the average of 4.11 of the last 4 quarters.

LB Pharmaceuticals Inc Common Stock (LBRX) Historical Current Ratio (quarterly & annually)

How has LBRX Current Ratio performed in the past?

The mean historical Current Ratio of LB Pharmaceuticals Inc Common Stock over the last ten years is 22.30. The current 3.56 Current Ratio has changed 1.50% with respect to the historical average. Over the past ten years (40 quarters), LBRX's Current Ratio was at its highest in in the March 2024 quarter at 8.55. The Current Ratio was at its lowest in in the June 2024 quarter at 0.

LB Pharmaceuticals Inc Common Stock (LBRX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of LB Pharmaceuticals Inc Common Stock Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

LB Pharmaceuticals Inc Common Stock (LBRX) Average Current Ratio

How has LBRX Current Ratio performed in the past?

The current Current Ratio of LB Pharmaceuticals Inc Common Stock (LBRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

LB Pharmaceuticals Inc Common Stock (LBRX) Current Ratio vs. Peers

How is LBRX’s Current Ratio compared to its peers?

LB Pharmaceuticals Inc Common Stock’s Current Ratio is less than Rocket Pharmaceuticals, Inc. (7.30), less than Aura Biosciences, Inc. (12.39), less than Annexon, Inc. (5.67), less than Solid Biosciences Inc. (6.74), less than Larimar Therapeutics, Inc. (5.46), less than Altimmune, Inc. (17.18), less than Autolus Therapeutics plc (8.43), greater than DBV Technologies S.A. (2.45), less than Design Therapeutics, Inc. (25.13), less than Korro Bio, Inc. (5.98),

Build a custom stock screener for LB Pharmaceuticals Inc Common Stock (LBRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LB Pharmaceuticals Inc Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

LB Pharmaceuticals Inc Common Stock (LBRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like LB Pharmaceuticals Inc Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.